Apollo in Talks to Buy J&J's Orthopedics Unit for ~$20B
APO sits 28% above its 52-week low of $99.56.
Summary
Apollo Global is in talks to acquire Johnson & Johnson's orthopedics unit at a valuation near $20 billion, according to Bloomberg News. The deal would be a major expansion of Apollo's healthcare portfolio and a significant divestiture for J&J. If completed, it would be one of Apollo's largest acquisitions and could reshape the orthopedics market. No agreement has been reached, and terms may change.
At the time of this announcement, APO was trading at $127.75 on NYSE in the Life Sciences sector, with a market capitalization of approximately $76.2B. The 52-week trading range was $99.56 to $153.29. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.